Enteral Feeding Formulas Market Expected to Reach $12.7 Billion by 2032—Allied Market Research

According to a new report published by Allied Market Research, titled, “Enteral Feeding Formulas Market," The Enteral Feeding Formulas Market was valued at $6.3 billion in 2022, and is estimated to reach $12.7 billion by 2032, growing at a CAGR of 7.4% from 2023 to 2032. Enteral feeding formulas, often referred to as tube feeding formulas, are specialized nutritional products designed to provide essential nutrients to individuals who cannot consume food orally or have difficulty swallowing. Enteral feeding formulas are administered directly into the gastrointestinal tract through feeding tubes, which can be placed in the stomach or the small intestine. Enteral feeding formulas are used when a person's ability to take in food orally is compromised due to medical conditions such as dysphagia, neurological disorders, severe illnesses, or surgical procedures that require a temporary alternative to oral intake.
Factors that drive the growth of the Enteral Feeding Formulas Market size include the surge in the number of preterm births and the rise in awareness about the importance of nutrition by major key players.
The significant surge in the number of preterm births has emerged as a major driving force behind the remarkable growth of the Enteral Feeding Formulas Market. According to the Centers for Disease Control and Prevention, in 2021, it was estimated that preterm birth affected about 1 of every 10 infants born in the U.S. Preterm infants often face challenges in acquiring adequate nutrition and establishing proper feeding patterns due to their underdeveloped digestive systems and immature oral-motor skills. As a result, they frequently require alternative methods of feeding, such as enteral feeding, which involves providing nutrients directly to the gastrointestinal tract through tubes. The surge in preterm births has led to an increased focus on improving the quality and effectiveness of enteral feeding formulas. Manufacturers are investing in research and development to create advanced formulas that mimic the composition of human breast milk as closely as possible.
These formulas not only provide vital nutrients but also incorporate bioactive compounds that support immune function, gut health, and cognitive development, addressing the heightened vulnerability of preterm infants to infections and developmental challenges. For instance, Abbott Laboratories, a global pharmaceutical company, provides Similac human milk fortifier special care 30. Neonatal intensive care units (NICUs) and healthcare facilities are increasingly relying on these specialized formulas to ensure optimal growth and well-being in preterm infants, contributing significantly to the expansion of the enteral feeding formula market. Thus, the surge in preterm births has emerged as a significant driver for the Enteral Feeding Formulas Market Size.
In addition, a rise in awareness about the importance of nutrition by major key players is also expected to contribute actively to the growth of the Enteral Feeding Formulas Market share. For instance, in December 2021, Nestlé Health Science created a website in collaboration with healthcare professionals to offer information and support at every phase of the disease. The company emphasized the value of nutrition as part of a new initiative to inform and support cancer patients and their caregivers. There has been a surge in research shedding light on the intricate connections between nutrition and various health outcomes, including immune function, wound healing, and disease prevention. As a result, healthcare professionals and consumers alike have come to understand that tailored nutrition can play a fundamental role in the recovery process, particularly for patients with specific medical conditions or those recovering from surgeries.
The rise of health and wellness trends, coupled with the proliferation of information through digital platforms and social media, has empowered individuals to take charge of their health journeys and are a few of the major Enteral Feeding Formulas Market trends. As people increasingly recognize the direct link between what they consume and how they feel, there has been a growing demand for specialized nutrition solutions that cater to specific needs and dietary requirements. This has led to a surge in the demand for enteral feeding formulas that provide targeted nutrition to cater to diverse health goals. Thus, the rise in awareness about nutrition has positively impacted the market for enteral feeding formulas.
However, lower patient acceptance of the enteral feeding formulas might restrain the growth of the market.
On the basis of product type, the Enteral Feeding Formulas Market analysis is classified into standard formula, disease-specific formulas, peptide-based, and immune-modulating, blenderized. The standard formula segment was the largest revenue contributor to the market in 2022, owing to high adoption by healthcare professionals and cost-effectiveness. However, the disease-specific formulas segment is expected to register the fastest growth during the forecast period owing to the rise in the prevalence of chronic diseases.
On the basis of age group, the market is classified into adults and children. The adult segment was the highest revenue contributor to the market in 2022 and is the fastest-growing segment during the Enteral Feeding Formulas Market forecast period, due to the surge in the geriatric population and the high prevalence of chronic diseases among adults.
On the basis of application, the market is classified into cancer, neurological disorders, gastrointestinal disorders, malnutrition, and others. The neurological disorders segment was the highest revenue contributor to the market in 2022, owing to the surge in the prevalence of neurological disorders.
On the basis of end users, the market is classified into hospitals, long-term care facilities, and others. The hospital segment was the highest revenue contributor to the market in 2022, owing to the high adoption of enteral feeding formulas for the large patient base. 
On the basis of region, Europe has the highest Enteral Feeding Formulas Market share in 2022 and is expected to maintain its lead during the forecast period, owing to the rise in prevalence of chronic diseases and cancer well-developed healthcare infrastructure. However, Asia-Pacific is expected to exhibit the fastest growth during the forecast period, owing to the rise in geriatric population and preterm birth.

Key Findings of the Study 

• On the basis of product type, the standard formula segment was the highest contributor to the Enteral Feeding Formulas industry in 2022. However, the disease-specific formulas segment is expected to register the fastest growth during the forecasted period.
• On the basis of age group, the adult was the highest contributor to the market in 2022.
• On the basis of end users, the hospital segment was the highest contributor to the Enteral Feeding Formulas Industry in 2022.
• On the basis of region, Europe generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.